Milestone Pharmaceuticals (MIST) Income Statement (2018 - 2026)
Income Statement report data from Mar 31, 2018 to Mar 31, 2026 for Milestone Pharmaceuticals (MIST).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||||||
Total Revenue | 240K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||||||
Research And Development | 3.25M (-41.12%) | 5.52M (+40.10%) | 3.94M (+7.36%) | 3.67M (-26.31%) | 4.98M (+26.40%) | 3.94M (-0.51%) | 3.96M (+40.43%) | 2.82M (-22.53%) | 3.64M (-33.21%) | 5.45M (-18.90%) | 6.72M (-22.04%) | 8.62M (-15.98%) | 10M (-3.02%) | 11M (+7.63%) | 9.83M (-7.79%) | 11M (+21.55%) | 8.77M (-19.69%) | 11M (+12.23%) | 9.73M (+3.18%) | 9.43M (+9.65%) | 8.60M (+49.05%) | 5.77M (-29.89%) | 8.23M (-4.52%) | 8.62M (-27.38%) | 12M (-16.11%) | 14M (+48.17%) | 9.55M (-9.31%) | 11M (+35.52%) | 7.77M (+6.44%) | 7.30M (+86.70%) | 3.91M (+53.33%) | 2.55M (-17.48%) | 3.09M |
Selling General And Administrative | 4.82M (-5.30%) | 5.09M (+56.13%) | 3.26M (-13.30%) | 3.76M (-27.27%) | 5.17M (+29.25%) | 4.00M (+6.95%) | 3.74M (-25.94%) | 5.05M (+27.85%) | 3.95M (+17.21%) | 3.37M (-20.33%) | 4.23M (-4.94%) | 4.45M (+14.40%) | 3.89M (-5.58%) | 4.12M (+2.23%) | 4.03M (+2.81%) | 3.92M (+7.69%) | 3.64M (-3.96%) | 3.79M (+28.04%) | 2.96M (-1.99%) | 3.02M (+14.83%) | 2.63M (+57.49%) | 1.67M (-43.39%) | 2.95M (-0.34%) | 2.96M (+9.63%) | 2.70M (+18.42%) | 2.28M (+8.57%) | 2.10M (+28.05%) | 1.64M (+67.35%) | 980K (-19.67%) | 1.22M (+87.69%) | 650K (-13.33%) | 750K (+70.45%) | 440K |
Operating Expenses | 24M (+10291.30%) | 230K (-96.81%) | 7.20M (-3.10%) | 7.43M (-63.79%) | 21M (+158.44%) | 7.94M (+2.98%) | 7.71M (-1.91%) | 7.86M (+3.56%) | 7.59M (-13.95%) | 8.82M (-19.45%) | 11M (-16.22%) | 13M (-7.63%) | 14M (-3.74%) | 15M (+6.06%) | 14M (-4.94%) | 15M (+17.49%) | 12M (-15.58%) | 15M (+15.84%) | 13M (+1.93%) | 12M (+10.86%) | 11M (+50.94%) | 7.44M (-33.45%) | 11M (-3.45%) | 12M (-20.58%) | 15M (-11.26%) | 16M (+41.03%) | 12M (-4.27%) | 12M (+39.24%) | 8.74M (+2.70%) | 8.51M (+86.62%) | 4.56M (+38.18%) | 3.30M (-6.52%) | 3.53M |
Depreciation And Amortization | 60K (-33.33%) | 90K | - | - | 30K (-62.50%) | 80K | - | - | 30K (-57.14%) | 70K | - | - | 20K (-71.43%) | 70K | - | - | 20K (-71.43%) | 70K | - | - | 20K (-71.43%) | 70K | - | - | 20K (-50.00%) | 40K | - | - | - | 10K | - | - | - |
Operating Income | |||||||||||||||||||||||||||||||||
Operating Income | -23.66M (+37.08%) | -17.26M (+45.90%) | -11.83M (-5.59%) | -12.53M (-38.94%) | -20.52M (+66.15%) | -12.35M (+28.38%) | -9.62M (-0.41%) | -9.66M (-7.82%) | -10.48M (-24.06%) | -13.80M (-10.16%) | -15.36M (-6.57%) | -16.44M (+6.06%) | -15.50M (+12.65%) | -13.76M (-8.45%) | -15.03M (-10.59%) | -16.81M (+19.64%) | -14.05M (-16.96%) | -16.92M (+18.57%) | -14.27M | 710K | -12.59M (+43.72%) | -8.76M (-27.48%) | -12.08M (-7.79%) | -13.10M (-21.84%) | -16.76M (-11.28%) | -18.89M (+37.68%) | -13.72M (-4.26%) | -14.33M (+31.11%) | -10.93M (+8.11%) | -10.11M (+74.91%) | -5.78M (+57.07%) | -3.68M (-13.41%) | -4.25M |
Ebit | -23.66M (+37.08%) | -17.26M (+45.90%) | -11.83M (-5.59%) | -12.53M (-38.94%) | -20.52M (+66.15%) | -12.35M (+28.38%) | -9.62M (-0.41%) | -9.66M (-7.82%) | -10.48M (-24.06%) | -13.80M (-10.16%) | -15.36M (-6.57%) | -16.44M (+6.06%) | -15.50M (+12.65%) | -13.76M (-8.45%) | -15.03M (-10.59%) | -16.81M (+19.64%) | -14.05M (-16.96%) | -16.92M (+18.57%) | -14.27M | 710K | -12.59M (+43.72%) | -8.76M (-27.48%) | -12.08M (-7.79%) | -13.10M (-21.84%) | -16.76M (-11.28%) | -18.89M (+37.68%) | -13.72M (-4.26%) | -14.33M (+31.11%) | -10.93M (+8.11%) | -10.11M (+74.91%) | -5.78M (+57.07%) | -3.68M (-13.41%) | -4.25M |
EBITDA | -23.61M (+27.21%) | -18.56M (+69.50%) | -10.95M (-8.83%) | -12.01M (-41.41%) | -20.50M (+40.99%) | -14.54M (+70.26%) | -8.54M (+0.71%) | -8.48M (-18.85%) | -10.45M (-34.93%) | -16.06M (+12.78%) | -14.24M (-6.44%) | -15.22M (-1.68%) | -15.48M (+8.10%) | -14.32M (-1.65%) | -14.56M (-12.55%) | -16.65M (+18.76%) | -14.02M (-17.29%) | -16.95M (+19.20%) | -14.22M | 770K | -12.57M (+41.24%) | -8.90M (-25.83%) | -12.00M (-7.55%) | -12.98M (-22.41%) | -16.73M (-17.79%) | -20.35M (+57.75%) | -12.90M (-5.56%) | -13.66M (+24.98%) | -10.93M (+6.43%) | -10.27M (+80.18%) | -5.70M (+58.77%) | -3.59M (-15.53%) | -4.25M |
Other Income / Expenses | |||||||||||||||||||||||||||||||||
Interest Income | 1.73M (+108.43%) | 830K (-4.60%) | 870K (+67.31%) | 520K (-25.71%) | 700K (-22.22%) | 900K (-16.67%) | 1.08M (-9.24%) | 1.19M (+20.20%) | 990K (-5.71%) | 1.05M (-6.25%) | 1.12M (-7.44%) | 1.21M (+105.08%) | 590K | -630.00K | 470K (+193.75%) | 160K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 4.14M (+318.18%) | 990K (+2.06%) | 970K (+2.11%) | 950K (+1.06%) | 940K (+2.17%) | 920K (+2.22%) | 900K (+1.12%) | 890K (+2.30%) | 870K (+1.16%) | 860K (+2.38%) | 840K (+2.44%) | 820K (+2633.33%) | 30K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 1.73M (+108.43%) | 830K (-4.60%) | 870K (+67.31%) | 520K (-25.71%) | 700K (-60.67%) | 1.78M (+64.81%) | 1.08M (-9.24%) | 1.19M (+891.67%) | 120K (-36.84%) | 190K (-32.14%) | 280K (-28.21%) | 390K (-29.09%) | 550K | -630.00K | 470K (+193.75%) | 160K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||||||||||
Income Before Tax | - | -63.06M | - | - | - | -41.52M | - | - | - | -59.68M | - | - | - | -58.39M | - | - | - | -28.63M (+101.34%) | -14.22M | - | - | -37.99M (+216.58%) | -12.00M | - | - | - | - | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -20.00K | - | - | - | -70.00K | - | 20K (-66.67%) | 60K | - | - | 20K |
Net Income From Continuing Operations | -26.07M (+49.74%) | -17.41M (+46.06%) | -11.92M (-8.10%) | -12.97M (-37.52%) | -20.76M (+67.96%) | -12.36M (+30.93%) | -9.44M (+0.85%) | -9.36M (-9.57%) | -10.35M (-23.95%) | -13.61M (-9.75%) | -15.08M (-5.99%) | -16.04M (+7.29%) | -14.95M (+13.43%) | -13.18M (-9.48%) | -14.56M (-12.55%) | -16.65M (+18.84%) | -14.01M (-17.00%) | -16.88M (+18.71%) | -14.22M | 770K | -12.51M (+44.29%) | -8.67M (-27.63%) | -11.98M (-7.70%) | -12.98M (-20.56%) | -16.34M (-10.66%) | -18.29M (+42.56%) | -12.83M (-6.08%) | -13.66M (+30.72%) | -10.45M (+7.62%) | -9.71M (+70.35%) | -5.70M (+58.77%) | -3.59M (-14.11%) | -4.18M |
Net Income | -26.07M (+49.74%) | -17.41M (+46.06%) | -11.92M (-8.10%) | -12.97M (-37.52%) | -20.76M (+67.96%) | -12.36M (+30.93%) | -9.44M (+0.85%) | -9.36M (-9.57%) | -10.35M (-23.95%) | -13.61M (-9.75%) | -15.08M (-5.99%) | -16.04M (+7.29%) | -14.95M (+13.43%) | -13.18M (-9.48%) | -14.56M (-12.55%) | -16.65M (+18.84%) | -14.01M (-17.00%) | -16.88M (+18.71%) | -14.22M | 770K | -12.51M (+44.29%) | -8.67M (-27.63%) | -11.98M (-7.70%) | -12.98M (-20.56%) | -16.34M (-10.66%) | -18.29M (+42.56%) | -12.83M (-6.08%) | -13.66M (+30.72%) | -10.45M (+7.62%) | -9.71M (+70.35%) | -5.70M (+58.77%) | -3.59M (-14.11%) | -4.18M |